DR

Dr Srividhya Ravi

Senior Pharmacovigilance Physician at Medical Developments International (MDI)

Dr. Srividhya Ravi is a highly experienced medical professional specializing in pharmacovigilance and patient care. Currently serving as a Senior Pharmacovigilance Physician at Medical Developments International since January 2021, Dr. Ravi has previously worked as a Safety Physician at Lundbeck and as a Resident Medical Officer at Sre Iswarrya Hospital. Earlier roles include providing critical care as a Resident Doctor at East Coast Hospitals Ltd and Apollo Hospitals, and managing teams as a General Practitioner at SRI MUTHUKUMARAN MEDICAL COLLEGE HOSPITAL AND RESEARCH INSTITUTE. Dr. Ravi’s foundational medical education was completed at Mahatma Gandhi Medical College and Research Institute, culminating in an MBBS degree in 2014, with a strong focus on cardiology throughout various residency positions.

Location

Melbourne, Australia

Links


Org chart

This person is not in the org chart


Teams


Offices


Medical Developments International (MDI)

"Delivering emergency medical solutions dedicated to improving patient outcomes"​ Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971. MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia. MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia. MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.


Employees

51-200

Links